• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围绝经期疾病的管理:激素治疗。

Management of perimenopause disorders: hormonal treatment.

机构信息

Department of Molecular and Developmental Medicine, Obstetrics and Gynecology, University of Siena, Siena, Italy.

出版信息

Gynecol Endocrinol. 2021 Mar;37(3):195-200. doi: 10.1080/09513590.2020.1852544. Epub 2020 Dec 2.

DOI:10.1080/09513590.2020.1852544
PMID:33263443
Abstract

Perimenopause represents a transition period of a woman's life during which physiological, affective, psychological, and social changes mark progression from a woman's fertile life to menopause, with wide sexual hormones fluctuations until the onset of hypergonadotropic hypogonadic amenorrhea. Contraception during menopause should not only avoid unwanted pregnancies, but also improve quality of life and prevent wide range of condition affecting this population. Hormonal contraceptives confer many noncontraceptive benefits for women approaching menopause: treatment of abnormal uterine bleeding, relief from vasomotor symptoms, endometrial protection in women using estrogen therapy, musculoskeletal protection, and mood disorders protection. The main point remains selecting the most adequate contraceptive option for each woman, considering her risk factor, comorbidities, and keeping in mind the possibility of continuing contraception until reaching menopause and even further, creating a bridge between perimenopause and menopause hormonal therapy. Correct perimenopause management should rely on individualized medical therapy and multidisciplinary approach considering lifestyle and food habits as part of general good health of a woman.

摘要

围绝经期是女性生命中的一个过渡阶段,在此期间,生理、情感、心理和社会变化标志着女性从生育期向绝经的转变,广泛的性激素波动直到高促性腺激素性闭经的发生。围绝经期的避孕不仅要避免意外怀孕,还要提高生活质量,预防影响这一人群的多种疾病。激素避孕为接近绝经的女性带来了许多非避孕益处:治疗异常子宫出血、缓解血管舒缩症状、保护使用雌激素治疗的女性的子宫内膜、保护肌肉骨骼、保护情绪障碍。主要问题仍然是为每个女性选择最合适的避孕方法,考虑她的风险因素、合并症,并牢记可能继续避孕直到绝经,甚至更远,在围绝经期和绝经激素治疗之间架起一座桥梁。正确的围绝经期管理应依赖于个体化的医学治疗和多学科方法,将生活方式和饮食习惯作为女性整体健康的一部分来考虑。

相似文献

1
Management of perimenopause disorders: hormonal treatment.围绝经期疾病的管理:激素治疗。
Gynecol Endocrinol. 2021 Mar;37(3):195-200. doi: 10.1080/09513590.2020.1852544. Epub 2020 Dec 2.
2
Contraception and hormonal management in the perimenopause.围绝经期的避孕与激素管理
J Womens Health (Larchmt). 2015 Jan;24(1):3-10. doi: 10.1089/jwh.2013.4544. Epub 2014 Apr 28.
3
Contraception for the perimenopausal woman.围绝经期女性的避孕
Climacteric. 2016 Dec;19(6):526-534. doi: 10.1080/13697137.2016.1225033. Epub 2016 Sep 24.
4
Contraception during perimenopause.围绝经期的避孕
Eur J Contracept Reprod Health Care. 2005 Mar;10(1):19-25. doi: 10.1080/13625180400020861.
5
Contraception during the perimenopause.围绝经期避孕。
Maturitas. 2013 Nov;76(3):235-42. doi: 10.1016/j.maturitas.2013.07.009. Epub 2013 Aug 8.
6
[Contraception during the perimenopause].
Presse Med. 2003 Apr 12;32(14):647-54.
7
Use of hormonal contraceptives in perimenopause: A systematic review.围绝经期激素避孕药的使用:一项系统综述。
Pharmacotherapy. 2022 Feb;42(2):154-164. doi: 10.1002/phar.2657. Epub 2022 Feb 10.
8
Perimenopausal contraception.围绝经期避孕。
Curr Opin Obstet Gynecol. 2020 Dec;32(6):399-407. doi: 10.1097/GCO.0000000000000667.
9
The contraception needs of the perimenopausal woman.围绝经期女性的避孕需求。
Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):903-15. doi: 10.1016/j.bpobgyn.2014.05.006. Epub 2014 Jun 5.
10
[The use of hormonal contraception in perimenopause is still a hazard?].[围绝经期使用激素避孕仍存在风险?]
Minerva Ginecol. 2001 Dec;53(6):421-9.

引用本文的文献

1
Progesterone-induced activation of progesterone receptor alleviates alveolar bone resorption and inflammatory response in periodontitis.孕酮诱导的孕酮受体激活可减轻牙周炎中的牙槽骨吸收和炎症反应。
Clin Oral Investig. 2025 Sep 11;29(10):446. doi: 10.1007/s00784-025-06473-4.
2
Slowing down the clock on ovarian aging-does the ovary hold the secret to the fountain of youth?延缓卵巢衰老的时钟——卵巢掌握着青春永驻的秘密吗?
Geroscience. 2025 Sep 10. doi: 10.1007/s11357-025-01876-3.
3
Insights into Perimenopause: A Survey of Perceptions, Opinions on Treatment, and Potential Approaches.
围绝经期洞察:关于认知、治疗意见及潜在方法的调查
Women (Basel). 2025 Mar;5(1). doi: 10.3390/women5010004. Epub 2025 Jan 31.
4
Sleep Disturbance and Perimenopause: A Narrative Review.睡眠障碍与围绝经期:一项叙述性综述
J Clin Med. 2025 Feb 23;14(5):1479. doi: 10.3390/jcm14051479.
5
Progesterone affects periodontitis in perimenopausal women and in an experimental rat model.孕酮对围绝经期女性及实验性大鼠模型的牙周炎有影响。
J Dent Sci. 2025 Jan;20(1):452-461. doi: 10.1016/j.jds.2024.05.020. Epub 2024 May 24.
6
Effects of key physiological parameters on cardiovascular disease and osteoporosis risk in perimenopausal and postmenopausal women.关键生理参数对围绝经期和绝经后女性心血管疾病及骨质疏松症风险的影响。
Sci Rep. 2025 Jan 22;15(1):2814. doi: 10.1038/s41598-025-86613-8.
7
Petroclival meningioma regression after combined oestrogen and nomegestrol acetate interruption.联合使用雌激素和醋酸诺美孕酮停药后岩斜区脑膜瘤消退
BMJ Case Rep. 2025 Jan 19;18(1):e263529. doi: 10.1136/bcr-2024-263529.
8
Association of Changes in Relevant Indicators With Cardiovascular Disease and Osteoporosis in Perimenopausal and Postmenopausal Women.围绝经期和绝经后女性相关指标变化与心血管疾病和骨质疏松症的关联
Food Sci Nutr. 2024 Nov 6;12(12):10296-10305. doi: 10.1002/fsn3.4512. eCollection 2024 Dec.
9
The application value of 5 Fr non-contact hysteroscopy in the diagnosis and treatment of intrauterine diseases in perimenopausal and postmenopausal women.5Fr非接触式宫腔镜在围绝经期及绝经后女性子宫内疾病诊断与治疗中的应用价值
BMC Surg. 2024 Dec 4;24(1):384. doi: 10.1186/s12893-024-02680-0.
10
The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women-A Pilot Randomized Clinical Trial.白藜芦醇和维生素 C 联合管理可降低绝经后妇女的氧化应激:一项初步随机临床试验。
Nutrients. 2024 Nov 3;16(21):3775. doi: 10.3390/nu16213775.